Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Bradley Arms-Williams, A. Barney Hawthorne, Rebecca Cannings-John, Alexander Berry, Philip Harborne & Anjali Trivedi. (2023) Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005–2016. Scandinavian Journal of Gastroenterology 58:6, pages 619-626.
Read now
Read now
Yaroslava Zhulina, Ruzan Udumyan, Curt Tysk & Jonas Halfvarson. (2022) Mortality in patients with Crohn’s disease in Örebro, Sweden 1963–2010. Scandinavian Journal of Gastroenterology 57:2, pages 158-164.
Read now
Read now
Bing-xia Chen, Ze-min Han, Qian Zhou, Hong-bin Liu, Pei-chun Xu & Fa-chao Zhi. (2021) Efficacy of infliximab in treatment-naïve patients with stricturing small bowel Crohn’s disease. Scandinavian Journal of Gastroenterology 56:7, pages 812-819.
Read now
Read now
Cátia Arieira, Tiago Cúrdia Gonçaves, Francisca Dias de Castro, Maria João Moreira & José Cotter. (2018) Clinical course in Crohn’s disease: factors associated with behaviour change and surgery. Scandinavian Journal of Gastroenterology 53:10-11, pages 1222-1227.
Read now
Read now
Nikoletta A. Theochari, Anastasios Stefanopoulos, Konstantinos S. Mylonas & Konstantinos P. Economopoulos. (2018) Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scandinavian Journal of Gastroenterology 53:1, pages 1-7.
Read now
Read now
Vu Nguyen, Rajan Kanth, Joshua Gazo & Dario Sorrentino. (2016) Management of post-operative Crohn’s disease in 2017: where do we go from here?. Expert Review of Gastroenterology & Hepatology 10:11, pages 1257-1269.
Read now
Read now
Articles from other publishers (24)
Johan Burisch. (2023) Long‐term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort. APMIS 131:S147, pages 1-46.
Crossref
Crossref
Yajun Liu, Feiyan Tian, Shuijiao Chen & jiuye Hu. (2023) Improved comprehensive evaluation of Crohn’s disease activity by intestinal computed tomography enterography combined with endoscopy and biochemical indicators. Arab Journal of Gastroenterology 24:1, pages 16-23.
Crossref
Crossref
Åsa H Everhov, Thordis Disa Kalman, Jonas Söderling, Caroline Nordenvall, Jonas Halfvarson, Anders Ekbom, Jonas F Ludvigsson, Ola Olén & Pär Myrelid. (2022) Probability of Stoma in Incident Patients With Crohn’s Disease in Sweden 2003-2019: A Population-based Study. Inflammatory Bowel Diseases 28:8, pages 1160-1168.
Crossref
Crossref
Sharafaath Shariff, Gordon Moran, Caris Grimes & Rachel Margaret Cooney. (2021) Current Use of EEN in Pre-Operative Optimisation in Crohn’s Disease. Nutrients 13:12, pages 4389.
Crossref
Crossref
Satimai Aniwan & Edward V. LoftusJrJr. (2021) The Natural History of Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 19:4, pages 597-607.
Crossref
Crossref
Lester Tsai, Christopher Ma, Parambir S. Dulai, Larry J. Prokop, Samuel Eisenstein, Sonia L. Ramamoorthy, Brian G. Feagan, Vipul Jairath, William J. Sandborn & Siddharth Singh. (2021) Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease: A Meta-Analysis of Population-Based Cohorts. Clinical Gastroenterology and Hepatology 19:10, pages 2031-2045.e11.
Crossref
Crossref
Mirabella Zhao, Lóránt Gönczi, Peter L Lakatos & Johan Burisch. (2021) The Burden of Inflammatory Bowel Disease in Europe in 2020. Journal of Crohn's and Colitis 15:9, pages 1573-1587.
Crossref
Crossref
Pauline Rivière, Séverine Vermeire, Marie Irles-Depe, Gert Van Assche, Paul Rutgeerts, Quentin Denost, Albert Wolthuis, Andre D’Hoore, David Laharie & Marc Ferrante. (2021) Rates of Postoperative Recurrence of Crohn’s Disease and Effects of Immunosuppressive and Biologic Therapies. Clinical Gastroenterology and Hepatology 19:4, pages 713-720.e1.
Crossref
Crossref
Hong Lv, Meng Jin, Huimin Zhang, Xuanfu Chen, Meixu Wu, Mingyue Guo, Runing Zhou, Zheng Wang, Hong Yang & Jiaming Qian. (2020) Increasing newly diagnosed inflammatory bowel disease and improving prognosis in China: a 30-year retrospective study from a single centre. BMC Gastroenterology 20:1.
Crossref
Crossref
Johan Burisch, Daniel Bergemalm, Jonas Halfvarson, Viktor Domislovic, Zeljko Krznaric, Adrian Goldis, Jens F Dahlerup, Pia Oksanen, Pekka Collin, Luisa Castro, Vicent Hernandez, Svetlana Turcan, Elena Belousova, Renata D’Incà, Alessandro Sartini, Daniela Valpiani, Martina Giannotta, Ravi Misra, Naila Arebi, Dana Duricova, Martin Bortlik, Kelly Gatt, Pierre Ellul, Natalia Pedersen, Jens Kjeldsen, Karina W Andersen, Vibeke Andersen, Konstantinos H Katsanos, Dimitrios K Christodoulou, Shaji Sebastian, Luisa Barros, Fernando Magro, Jóngerð MM Midjord, Kári R Nielsen, Riina Salupere, Hendrika AL Kievit, Gediminas Kiudelis, Juozas Kupčinskas, Mathurin Fumery, Corinne Gower‐Rousseau, Ioannis P Kaimakliotis, Doron Schwartz, Selwyn Odes, Laszlo Lakatos, Peter L Lakatos, Ebbe Langholz & Pia Munkholm. (2020) The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study. United European Gastroenterology Journal 8:8, pages 949-960.
Crossref
Crossref
T D Kalman, Å H Everhov, C Nordenvall, M C Sachs, J Halfvarson, A Ekbom, J F Ludvigsson, P Myrelid & O Olén. (2020) Decrease in primary but not in secondary abdominal surgery for Crohn's disease: nationwide cohort study, 1990–2014. British Journal of Surgery 107:11, pages 1529-1538.
Crossref
Crossref
Akihito Uda, Hiroyo Kuwabara, Sayuri Shimizu, Ryuichi Iwakiri & Kiyohide Fushimi. (2020) Optimal use of biologics with endoscopic balloon dilatation for repeated intestinal strictures in Crohn's disease. JGH Open 4:3, pages 532-540.
Crossref
Crossref
Johan Burisch, Hillel Vardi, Doron Schwartz, Michael Friger, Gediminas Kiudelis, Juozas Kupčinskas, Mathurin Fumery, Corinne Gower-Rousseau, Laszlo Lakatos, Peter L Lakatos, Renata D'Incà, Alessandro Sartini, Daniela Valpiani, Martina Giannotta, Naila Arebi, Dana Duricova, Martin Bortlik, Stefania Chetcuti Zammit, Pierre Ellul, Natalia Pedersen, Jens Kjeldsen, Jóngerð Maria Miné Midjord, Kári Rubek Nielsen, Karina Winther Andersen, Vibeke Andersen, Konstantinos H Katsanos, Dimitrios K Christodoulou, Viktor Domislovic, Zeljko Krznaric, Shaji Sebastian, Pia Oksanen, Pekka Collin, Luisa Barros, Fernando Magro, Riina Salupere, Hendrika Adriana Linda Kievit, Adrian Goldis, Ioannis P Kaimakliotis, Jens F Dahlerup, Carl Eriksson, Jonas Halfvarson, Alberto Fernandez, Vicent Hernandez, Svetlana Turcan, Elena Belousova, Ebbe Langholz, Pia Munkholm, Selwyn Odes, Niksa Turk, Silvija Cukovic-Cavka, Anastasia Nicolaou, Milan Lukas, Olga Shonová, Birgitte Blichfeldt, Dorte Marker, Katrine Carlsen, Petra Weimers, Clays Aalykke, Karen Kudsk, Ida Vind, Niels Thorsgaard, Alexandros Skamnelos, Dimitrios Politis, Zsuzsanna Vegh, Peterne Demenyi, Szabina Nemethne Kramli, Giualia Dal Piaz, Alessia Santini, Giulia Girardin, Limas Kupcinskas, Laimas Jonaitis, Irena Valantiene, Romanas Zykus, Ruta Kucinskiene, Daniela Lazar, Inna Nikulina, Luisa de Castro, Juan-Ramon Pineda, Santos Pereira, Jesus Martinez-Cadilla, Luciano Sanroman, Montserrat Figueira, David Martinez Ares, Jose-Ignacio Rodriguez-Prada, Amalia Carmona, Carlos Gonzalez-Portela, Ulla-Britt Widen, Sally Myers, Katherine Ashton & Emma Whitehead. (2020) Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study. The Lancet Gastroenterology & Hepatology 5:5, pages 454-464.
Crossref
Crossref
Julajak Limsrivilai, Satimai Aniwan, Asawin Sudcharoen, Natapat Chaisidhivej, Piyaphan Prueksapanich, Nonthalee Pausawasdi, Phunchai Charatcharoenwitthaya, Supot Pongprasobchai & Sathaporn Manassatit. (2020) Temporal trend of disease recognition, treatment paradigm, and clinical outcomes of Crohn disease in Thailand from 2000 through 2017. Medicine 99:38, pages e22216.
Crossref
Crossref
J. Alfredo Blakeley-Ruiz, Alison R. Erickson, Brandi L. Cantarel, Weili Xiong, Rachel Adams, Janet K. Jansson, Claire M. Fraser & Robert L. Hettich. (2019) Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn’s remission patients despite temporal variations in microbial taxa, genomes, and proteomes. Microbiome 7:1.
Crossref
Crossref
Johan Burisch, Gediminas Kiudelis, Limas Kupcinskas, Hendrika Adriana Linda Kievit, Karina Winther Andersen, Vibeke Andersen, Riina Salupere, Natalia Pedersen, Jens Kjeldsen, Renata D’Incà, Daniela Valpiani, Doron Schwartz, Selwyn Odes, Jóngerð Olsen, Kári Rubek Nielsen, Zsuzsanna Vegh, Peter Laszlo Lakatos, Alina Toca, Svetlana Turcan, Konstantinos H Katsanos, Dimitrios K Christodoulou, Mathurin Fumery, Corinne Gower-Rousseau, Stefania Chetcuti Zammit, Pierre Ellul, Carl Eriksson, Jonas Halfvarson, Fernando Jose Magro, Dana Duricova, Martin Bortlik, Alberto Fernandez, Vicent Hernández, Sally Myers, Shaji Sebastian, Pia Oksanen, Pekka Collin, Adrian Goldis, Ravi Misra, Naila Arebi, Ioannis P Kaimakliotis, Inna Nikuina, Elena Belousova, Marko Brinar, Silvija Cukovic-Cavka, Ebbe Langholz & Pia Munkholm. (2019) Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut 68:3, pages 423-433.
Crossref
Crossref
D. Mege, K. Garrett, J. Milsom, T. Sonoda & F. Michelassi. (2019) Changing trends in surgery for abdominal Crohn's disease. Colorectal Disease 21:2, pages 200-207.
Crossref
Crossref
Anabela Rocha, Inês Bessa, Paula Lago, Marisa D. Santos, Júlio Leite & Fernando Castro-Poças. (2019) Preoperative Enteral Nutrition and Surgical Outcomes in Adults with Crohn’s Disease: A Systematic Review. GE - Portuguese Journal of Gastroenterology 26:3, pages 184-195.
Crossref
Crossref
Carl Eriksson, Ida Henriksson, Ole Brus, Yaroslava Zhulina, Nils Nyhlin, Curt Tysk, Scott Montgomery & Jonas Halfvarson. (2018) Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study. Alimentary Pharmacology & Therapeutics 48:6, pages 638-645.
Crossref
Crossref
Steven F G Jeuring, Vince B C Biemans, Tim R A van den Heuvel, Maurice P Zeegers, Wim H Hameeteman, Mariëlle J L Romberg-Camps, Liekele E Oostenbrug, Ad A M Masclee, Daisy M A E Jonkers & Marieke J Pierik. (2018) Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era—Results from the Dutch Population-Based IBDSL Cohort. American Journal of Gastroenterology 113:3, pages 384-395.
Crossref
Crossref
Silvio Danese, Gionata Fiorino & Laurent Peyrin-Biroulet. (2017) Early intervention in Crohn’s disease: towards disease modification trials. Gut 66:12, pages 2179-2187.
Crossref
Crossref
Christopher Ma, Gordon W Moran, Eric I Benchimol, Laura E Targownik, Steven J Heitman, James N Hubbard, Cynthia H Seow, Kerri L Novak, Subrata Ghosh, Remo Panaccione & Gilaad G Kaplan. (2017) Surgical Rates for Crohn’s Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study. American Journal of Gastroenterology 112:12, pages 1840-1848.
Crossref
Crossref
C. Eriksson, Y. Cao, S. Rundquist, Y. Zhulina, I. Henriksson, S. Montgomery & J. Halfvarson. (2017) Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963-2010. Alimentary Pharmacology & Therapeutics 46:8, pages 748-757.
Crossref
Crossref
Tadakazu Hisamatsu. (2017) Recent Advances in the Medical Treatment of Crohn's Disease. Nippon Daicho Komonbyo Gakkai Zasshi 70:10, pages 601-610.
Crossref
Crossref